SOL Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,350
Closed -$308K 55
2025
Q4
$308K Sell
1,350
-15
-1% -$3.42K 0.03% 272
2025
Q3
$316K Hold
1,365
0.03% 265
2025
Q2
$253K Hold
1,365
0.02% 280
2025
Q1
$286K Hold
1,365
0.03% 269
2024
Q4
$243K Hold
1,365
0.03% 282
2024
Q3
$270K Hold
1,365
0.03% 273
2024
Q2
$234K Hold
1,365
0.03% 278
2024
Q1
$249K Hold
1,365
0.03% 278
2023
Q4
$212K Buy
1,365
+15
+1% +$2.19K 0.03% 286
2023
Q3
$201K Sell
1,350
-300
-18% -$44K 0.03% 284
2023
Q2
$222K Buy
1,650
+171
+12% +$25.1K 0.03% 267
2023
Q1
$236K Hold
1,479
0.04% 265
2022
Q4
$239K Buy
+1,479
New +$227K 0.04% 258
2022
Q3
Sell
-1,479
Closed -$227K 266
2022
Q2
$227K Hold
1,479
0.05% 243
2022
Q1
$240K Sell
1,479
-172
-10% -$25K 0.04% 244
2021
Q4
$224K Buy
+1,651
New +$195K 0.04% 244

Other funds holding ABBV